Sergio Sandoval-Alarcon | Medicine and Health Sciences | Best Review Paper Award

Posted on by Research Hypothesis

Mr. Sergio Sandoval-Alarcon | Medicine and Health Sciences | Best Review Paper Award

Mr. Sergio Sandoval Alarcon | Medicine and Health Sciences | PhD Student at Universidad de Valparaiso | Chile

Dr. Sergio Sandoval-Alarcón is a seasoned Chilean academic and Associate Professor at the School of Kinesiology, Faculty of Medicine, Universidad de Valparaíso. With over two decades of experience in teaching, clinical practice, and curriculum development, he has made significant contributions to the fields of clinical biomechanics, ergonomics, and anatomy education. His research emphasizes improving musculoskeletal health through ergonomic interventions, as demonstrated by his recent publication in the Q1-ranked Applied Ergonomics. Dr. Sandoval-Alarcón holds a Master’s degree in Clinical Biomechanical Assessment and numerous postgraduate diplomas in areas such as scientific research, university teaching, and manual therapy. He has pioneered educational innovations using digital platforms for anatomy instruction and has been a key figure in developing kinesiology programs across multiple Chilean universities. His dedication to health promotion, interdisciplinary collaboration, and pedagogical advancement underscores his commitment to both academic excellence and public health impact.

Professional Profile 

Education 

Dr. Sergio Sandoval-Alarcón has built a robust academic foundation grounded in health sciences and clinical biomechanics. He earned his Bachelor’s degree in Kinesiology with Highest Distinction in 1999 from the Universidad Católica del Maule, Chile, followed by his Master’s degree in Clinical Biomechanical Assessment in 2016 from the prestigious Instituto de Biomecánica de Valencia (IBV), Universitat Politècnica de València, Spain. To further enrich his expertise, he has completed a wide range of postgraduate diplomas and certifications in scientific research, manual therapy, university teaching, coaching, health promotion, and competency-based training. These include programs from the Universidad de Chile, Pontificia Universidad Católica de Chile, Universidad de Playa Ancha, and Universidad de Talca, among others. His diverse and continuous educational journey reflects a deep commitment to lifelong learning and academic excellence.

Professional Experience 

Dr. Sergio Sandoval-Alarcón brings over two decades of rich and diverse professional experience in academia, clinical practice, and health education. He currently serves as an Associate Professor at the School of Kinesiology, Faculty of Medicine, Universidad de Valparaíso, where he has been a tenured faculty member since 2006. His teaching portfolio includes key subjects such as Human Anatomy, Biomechanics, and Clinical Kinesiology, and he has also led curriculum design and innovation initiatives. Beyond the classroom, he has served as a lecturer at several Chilean universities including Universidad de Playa Ancha, Universidad Andrés Bello, and Universidad de Aconcagua. Clinically, he worked extensively in primary health care settings, specializing in musculoskeletal and cardiovascular rehabilitation. Additionally, he has held leadership roles such as Program Director of Kinesiology at Universidad del Mar and has supervised numerous clinical internships and teaching diplomas. His career demonstrates a strong commitment to integrating academic rigor with community health needs.

Research Interests 

Dr. Sergio Sandoval-Alarcón’s research interests lie at the intersection of clinical biomechanics, ergonomics, and health education. He is particularly focused on the biomechanical assessment of human movement and the prevention of work-related musculoskeletal disorders, aiming to improve both clinical outcomes and workplace health. His studies often explore how ergonomic interventions can enhance physical function and reduce injury, especially in high-risk professions like dentistry. In parallel, he is deeply engaged in educational innovation, investigating digital methodologies for teaching anatomy and kinesiology, including the use of social media platforms for academic engagement. Through both applied clinical research and pedagogical development, Dr. Sandoval-Alarcón contributes to advancing health sciences in a multidisciplinary and impactful way.

Awards and Honors 

While Dr. Sergio Sandoval-Alarcón’s CV does not explicitly list formal awards or honors, his professional achievements reflect significant recognition through academic promotions, leadership roles, and scholarly contributions. His appointment as a tenured Associate Professor at the Universidad de Valparaíso highlights his respected status within the academic community. Additionally, his peer-reviewed publications in high-impact journals, such as Applied Ergonomics, and his involvement in national conferences on pedagogical innovation demonstrate professional acknowledgment of his research and teaching excellence. His selection as a tutor and lecturer in multiple postgraduate programs and diplomas further signifies his standing as a trusted expert and educator in the fields of kinesiology and clinical biomechanics.

Publications Top Noted

Title: Impact of ergonomic interventions on musculoskeletal health and work performance in dentists and dental students: a scoping review
Year: 2025

Conclusion

Dr. Sergio Sandoval Alarcón is a strong and competitive candidate for the Best Review Paper Award, primarily on the strength of his 2025 scoping review in a top-tier journal and his deep expertise in clinical biomechanics and ergonomics. His academic maturity, teaching leadership, and commitment to evidence-based practice support his candidacy.

Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Prof. Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Professor at Univ of South Florida Taneja College of Pharmacy, United States

Professor Yashwant V. Pathak is a globally renowned pharmaceutical scientist, educator, and research leader with a distinguished academic and international career spanning over four decades. Currently serving as Associate Dean and Full Professor at the University of South Florida’s Taneja College of Pharmacy, he has made groundbreaking contributions in nanotechnology, drug delivery systems, nutraceuticals, and healthcare education. A recipient of prestigious honors such as the Fellowship of the American Association for the Advancement of Science (AAAS) and multiple Fulbright Fellowships, Dr. Pathak has conducted postdoctoral research at elite institutions and lectured in over 100 universities across 80+ countries. His scholarly output exceeds 5,200 citations with an h-index of 33, and he has authored and edited numerous influential books, including the award-winning Handbook of Space Pharmaceuticals. With significant roles in research leadership, global collaborations, and interdisciplinary education, Professor Pathak exemplifies the highest standards of innovation, academic excellence, and global impact in science.

Professional Profile 

🎓 Educational Journey of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s educational background reflects a dynamic fusion of science, management, and interdisciplinary expertise. He began his academic journey with a Bachelor of Pharmacy (B.Pharm, 1975) and a Master of Pharmacy (M.Pharm, 1977) in Pharmaceutical Technology from Nagpur University, India, laying a strong foundation in pharmaceutical sciences. He further advanced his specialization by earning a Ph.D. in Pharmaceutical Sciences (1989) from the same institution. Demonstrating a commitment to leadership and holistic development, he pursued an Executive MBA in Business Management (2009) and a Master of Science in Conflict Management (MSCM, 2010) from Sullivan University, USA, graduating Summa Cum Laude in both programs. This diverse educational portfolio has empowered Dr. Pathak with a rare blend of technical expertise, strategic thinking, and conflict resolution—making him a uniquely qualified academic leader and international research collaborator.

💼 Professional Experience of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak brings over four decades of rich and diverse professional experience across academia, industry, and global research institutions. Currently serving as Associate Dean for Faculty Affairs and Full Professor at the University of South Florida (USF), he has held key leadership roles including Chair of International Working Groups and Director of Nanotechnology Centers. His previous appointments include Assistant Dean for Research and Graduate Programs at Sullivan University, USA, and Director of R&D at Neos Therapeutics, Texas, reflecting his strong industry-academia interface. He has also served as a pharmaceutical consultant for international tech transfer and worked as a postdoctoral fellow and visiting scientist at esteemed global institutions including the University of Michigan (USA), Hebrew University (Israel), and Royal Free Hospital (UK). His expertise spans pharmaceutical R&D, academic administration, and interdisciplinary collaborations, and he has made significant contributions to institutional growth, research innovation, and global education.

🔬 Research Interests of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s research interests are at the forefront of interdisciplinary science, spanning nanotechnology-based drug delivery systems, pharmaceutical innovations, nutraceuticals, and space pharmaceuticals. His pioneering work in nanomedicine and siRNA delivery technologies has positioned him as a global authority in targeted and controlled drug delivery mechanisms. He is deeply engaged in exploring the impact of microgravity on drug formulations, contributing significantly to the emerging field of space pharmacology. Additionally, Dr. Pathak’s interest in artificial intelligence in healthcare, conflict management in scientific collaborations, and the development of functional foods and nutraceuticals demonstrates his commitment to integrating science with global health and policy challenges. His multidisciplinary approach not only advances pharmaceutical sciences but also addresses broader health and sustainability issues on an international scale.

🏆 Awards and Honors of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak has been the recipient of numerous prestigious national and international awards that reflect his outstanding contributions to science, education, and global collaboration. Most notably, he is a Fellow of the American Association for the Advancement of Science (AAAS), one of the highest honors in the scientific community. He has received four Fulbright Fellowships across countries such as Indonesia, South Africa, Colombia, and the Czech Republic—recognizing his expertise in nanotechnology and pharmaceutical sciences. His book Handbook of Space Pharmaceuticals received the Book of the Year Award (2022) from the International Academy of Aeronautics. He has also been honored with fellowships and grants from government agencies in Australia, Brazil, Ecuador, China, Nigeria, and the USA, including the Endeavour Executive Fellowship, CNPQ Fellowship, and Mandela Washington Fellowship. At the University of South Florida, he has been repeatedly recognized with Outstanding Faculty Awards, a Global Engagement Achievement Award, and the USF Outstanding Research Faculty Award, underscoring his leadership in academia and research.

🏁 Conclusion

His global impact, interdisciplinary leadership, prolific scholarly output, and academic excellence firmly position him as a trailblazer in pharmaceutical sciences and allied fields. His contributions reflect not only intellectual brilliance but also a deep commitment to global scientific collaboration and education.

📚 Publications of Jibamitra Ganguly

          1. Title: CAR T cells in solid tumors: challenges and opportunities
              Authors: F. Marofi, R. Motavalli, V.A. Safonov, L. Thangavelu, A.V. Yumashev, …
              Year: 2021
              Citations: 611

          2. Title: Nanoparticulate drug-delivery systems: an overview
              Authors: D. Thassu, Y. Pathak, M. Deleers
              Year: 2007
              Citations: 349

          3. Title: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
              Authors: A. Markov, L. Thangavelu, S. Aravindhan, A.O. Zekiy, M. Jarahian, …
              Year: 2021
              Citations: 310

         4. Title: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
             Authors: S. Moghadasi, M. Elveny, H.S. Rahman, W. Suksatan, A.T. Jalil, …
             Year: 2021
             Citations: 279

         5. Title: Drug delivery nanoparticles formulation and characterization
             Authors: Y. Pathak, D. Thassu
             Year: 2009
             Citations: 224

          6. Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
              Authors: F. Marofi, H.S. Rahman, Z.M.J. Al-Obaidi, A.T. Jalil, W.K. Abdelbasset, …
             Year: 2021
             Citations: 195

         7. Title: Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization
             Authors: A. Barkai, Y.V. Pathak, S. Benita
             Year: 1990
             Citations: 169

         8. Title: Ocular drug delivery: impact of in vitro cell culture models
             Authors: A. Solanki, S. Desai, A. Grover, A. Hirani, Y. Pathak, V. Sutariya
             Year: 2016
             Citations: 165

         9. Title: Surface modification of nanoparticles for targeted drug delivery
             Authors: P. Patel, A. Hanini, A. Shah, D. Patel, S. Patel, P. Bhatt, Y.V. Pathak
             Year: 2019
             Citations: 139

       10. Title: Targeting nanoparticles as drug delivery systems for cancer treatment
             Authors: K. Subramani, H. Hosseinkhani, A. Khraisat, M. Hosseinkhani, Y. Pathak
             Year: 2009
             Citations: 112

 

 

Xianjuan Zhang | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Ms. Xianjuan Zhang | Medicine and Health Sciences | Best Researcher Award 

Attending physician, at The Affiliated Hospital of Qingdao University, China.

Dr. Xianjuan Zhang is a rising virologist and clinical researcher at the Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University. She earned her Ph.D. and M.Sc. in Pathogen Biology from Qingdao University, dedicating her academic career to investigating the pathogenic mechanisms of Human Cytomegalovirus (HCMV). With a strong foundation in virology, molecular biology, and immune evasion strategies, she has published impactful studies in top-tier journals, including Cellular and Molecular Gastroenterology and Hepatology, PLoS One, and Molecular Neurobiology. Dr. Zhang’s work provides novel insights into virus-host interactions and opens avenues for potential therapeutic interventions. Her research excellence is matched by her dedication to academic service as a peer reviewer for the International Journal of Molecular Sciences. With a strong command of advanced laboratory and bioinformatics tools, Dr. Zhang continues to contribute significantly to the understanding of viral pathogenesis. 📖🧫🔍

Professional Profile

Scopus

🎓 Education 

Dr. Xianjuan Zhang pursued both her doctoral and master’s degrees in Pathogen Biology at Qingdao University, China. During her M.Sc. (2016–2019), she developed a strong grasp of virology and immunology fundamentals, laying the groundwork for her more advanced research pursuits. Her Ph.D. studies (2019–2023) were marked by in-depth exploration of Human Cytomegalovirus (HCMV) and its impact on host cells, where she utilized in vivo and in vitro models to unravel molecular and immunological interactions. She mastered a wide range of technical tools including CRISPR, qPCR, siRNA knockdown, Western blotting, and bioinformatics analysis, which enabled her to investigate virus-host mechanisms at a molecular level. Her academic journey reflects not only deep theoretical understanding but also a practical orientation toward translational virology research. Her graduate education laid the foundation for a promising research career focused on infection, immunity, and molecular pathogenesis. 🎓🧪📘

🧑‍🔬 Experience 

Dr. Zhang has amassed valuable academic and professional experience centered on virology and molecular biology. Since 2023, she has served as a peer reviewer for the International Journal of Molecular Sciences, where she evaluates cutting-edge research on host-pathogen interactions, immune modulation, and therapeutic strategies. This role reflects her standing in the scientific community and her expertise in viral pathogenesis. In her research role at the Affiliated Hospital of Qingdao University, Dr. Zhang contributes to multidisciplinary projects aimed at understanding the cellular impact of Human Cytomegalovirus. She collaborates with pathologists, microbiologists, and molecular biologists, enhancing both the quality and translational potential of her research. Her work spans embryonic development, immune suppression, and metabolic syndromes linked to viral infections. Dr. Zhang’s collaborative and peer-reviewed experience demonstrates her capability to contribute both as a researcher and a reviewer in high-impact scientific contexts. 🧬🧫👩‍⚕️

🔬 Research Interests 

Dr. Zhang’s research revolves around the complex interplay between viruses and their hosts, with a primary focus on Human Cytomegalovirus (HCMV). Her studies explore how HCMV modulates host immune systems through evasion mechanisms, particularly focusing on the IL10/STAT3 pathway and antigen presentation suppression in macrophages. She is interested in decoding the molecular mechanisms by which viral proteins interfere with embryonic development, hepatic functions, and neurogenesis, using transgenic mouse models. In addition, Dr. Zhang investigates the role of the gut microbiome and viral infections in metabolic diseases such as hepatic steatosis and gestational diabetes. Her work seeks to identify novel therapeutic targets and enhance understanding of virus-induced pathologies. By leveraging molecular biology, immunological assays, and bioinformatics, Dr. Zhang’s research aims to bridge laboratory findings with clinical applications, offering potential advancements in diagnostics and treatment strategies for viral infections. 🦠🧠💉

🏅 Awards 

Dr. Xianjuan Zhang is a nominee for excellence in early-career virology research due to her impactful studies and commitment to scientific advancement. Although still in the early stages of her professional journey, her work has been published in high-impact journals and widely cited by the virology research community. Her contributions to understanding the effects of HCMV on organ development and immune regulation have positioned her as a promising voice in the field. She has been actively engaged in academic service through peer review, demonstrating leadership and responsibility in maintaining scientific integrity. Her nominations stem from both research merit and her application of science to solve critical health issues. With a portfolio of interdisciplinary studies connecting virology, immunology, and metabolic health, Dr. Zhang is a compelling candidate for any early-career research excellence awards. 🏆📚🧪

📚 Top Noted Publications

Dr. Zhang has authored and co-authored several impactful research papers on Human Cytomegalovirus and its pathological mechanisms. Her publication record demonstrates a consistent focus on viral interference with host systems:

1. Zhang X., et al. (2022)

Title: Human Cytomegalovirus-IE2 Affects Embryonic Liver Development and Survival in Transgenic Mouse
Journal: Cellular and Molecular Gastroenterology and Hepatology
Volume: 14(2), Pages: 494–511
DOI: 10.1016/j.jcmgh.2022.01.002
Cited by: 14
Summary: This study investigates the effects of the human cytomegalovirus (HCMV) immediate-early protein 2 (IE2) on embryonic liver development. Using a transgenic mouse model, the researchers demonstrate that IE2 impairs hepatic development, leading to increased embryonic mortality, likely due to disrupted hepatocyte differentiation and survival mechanisms.

2. Zhang X., et al. (2025)

Title: HCMV-IE2 suppresses antigen presentation via IL10/STAT3 pathway
Journal: PLoS One
Volume: 20(5), Article ID: e0322334
DOI: 10.1371/journal.pone.0322334
Cited by: 3
Summary: This paper describes how HCMV-IE2 modulates host immune responses. Specifically, it shows that IE2 inhibits antigen presentation by upregulating IL-10 and activating the STAT3 signaling pathway, leading to immune evasion. This mechanism could contribute to persistent infection and immune suppression.

3. Niu D., Zhang X., et al. (2023)

Title: IE2 disrupts neural progenitor development
Journal: Molecular Neurobiology
Volume: 60(7), Pages: 3883–3897
DOI: 10.1007/s12035-023-03348-2
Cited by: 5
Summary: This study explores the neurodevelopmental impact of HCMV-IE2, showing that IE2 expression disrupts neural progenitor cell proliferation and differentiation. The findings suggest a molecular basis for HCMV-related neurodevelopmental disorders in congenital infections.

4. Zhou X., Zhang X., et al. (2023)

Title: Gut microbiota induces hepatic steatosis
Journal: Scientific Reports
Volume: 13(1), Article ID: 6701
DOI: 10.1038/s41598-023-33829-4
Cited by: 8
Summary: This article investigates the role of gut microbiota in liver fat accumulation. It finds that alterations in microbial composition can induce hepatic steatosis in mice, potentially via modulation of metabolic and inflammatory pathways. Zhang X.’s contribution adds insights into host-microbiome interactions and liver health.

5. Wang Y., Zhang X., et al. (2022)

Title: HCMV and gestational diabetes
Journal: PeerJ
Volume: 10, Article ID: e1293
DOI: 10.7717/peerj.1293
Cited by: 6
Summary: This study explores the association between HCMV infection and gestational diabetes mellitus (GDM). The authors suggest a potential link between HCMV-induced immune dysregulation and glucose intolerance during pregnancy, providing new insight into viral contributions to metabolic disorders.

Conclusion 

Dr. Xianjuan Zhang is a promising early-career researcher whose focused contributions to HCMV pathogenesis and host interactions are impactful and published in high-quality journals. Her technical capabilities, publication record, and reviewer role indicate a high level of scientific maturity for her career stage.

 

Gang LIU | Drug Discovery | Best Researcher Award

Posted on by Research Hypothesis

Gang LIU | Drug Discovery | Best Researcher Award

Prof Gang LIU, Tsinghua University, China

Prof. Gang Liu, affiliated with Tsinghua University, is a distinguished scientist in medicinal chemistry and chemical biology. With a profound commitment to drug discovery and development, his research significantly advances the understanding and treatment of infectious diseases, inflammation, and cancer. Prof. Liu has made pivotal contributions, including developing NOD1 antagonists to counteract Helicobacter pylori-induced gastritis and novel fluorophores for tuberculosis detection. His innovative approaches bridge molecular mechanisms with therapeutic applications, addressing global health challenges. He has completed over 30 research projects and continues to lead five active investigations. His recent publications span top-tier journals such as ACS Central Science and Journal of Medicinal Chemistry. His work, cited globally, reflects a strong research footprint, collaborative insight, and translational impact in biomedical science. Prof. Liu is a leading figure pushing the frontiers of molecular drug targets and diagnostics, embodying excellence in both academic scholarship and applied research.

Publication Profile

orcid

Education

While exact degrees are not specified in the provided data, Prof. Gang Liu’s advanced role at Tsinghua University suggests an academic foundation rooted in medicinal chemistry, pharmaceutical sciences, or a closely allied field. Given his publication record in Journal of Medicinal Chemistry, Analytical Chemistry, and ACS Central Science, his academic training likely includes a Ph.D. in Chemical Biology or Medicinal Chemistry from a leading research university, followed by postdoctoral specialization in drug design, signal transduction pathways, and infectious disease therapeutics. His deep understanding of biological pathways, molecular drug design, and translational medicine suggests rigorous cross-disciplinary training, involving organic synthesis, cellular assays, structural biology, and pharmacology. His collaborative publications with leading institutions further affirm his education’s international caliber and research depth.

Experience

Prof. Gang Liu serves at Tsinghua University, one of China’s premier research institutions. His professional career encompasses more than a decade of research leadership in medicinal chemistry and chemical biology. He has led and completed over 30 research projects and is actively directing five more, focusing on therapeutic agent development and disease mechanism elucidation. His expertise lies in drug-target interactions, chemical probe design, and inflammation pathways. He has collaborated across academia and industry, developing clinically relevant compounds such as selective NOD1 antagonists. Prof. Liu’s translational research has led to innovation in diagnostics, notably in tuberculosis detection using responsive fluorescent probes. His experience spans mentoring Ph.D. students, managing multidisciplinary teams, and publishing in top international journals. Prof. Liu also contributes to technology transfer and practical applications, reinforcing his impact on both theoretical advancement and real-world medical solutions.

Awards and Honors

Although no specific awards are listed, Prof. Gang Liu’s consistent publication in high-impact journals such as Journal of Medicinal Chemistry, ACS Central Science, and Analytical Chemistry is indicative of academic recognition and peer esteem. His groundbreaking development of a selective NOD1 antagonist for H. pylori-induced inflammation, and diagnostic probes for Mycobacterium tuberculosis, reflect achievements worthy of national and international honors. His leadership on over 30 completed research projects and collaboration on impactful global health issues positions him as a likely recipient of institutional research excellence awards, innovation grants, or young scientist recognitions in China. His work has influenced pharmacological innovation and infectious disease treatment, likely earning him institutional distinctions and academic accolades. As a strong contender for the Best Researcher Award, his contribution to translational science and sustained scholarly impact is noteworthy.

Research Focus

Prof. Gang Liu’s research lies at the intersection of medicinal chemistry, chemical biology, and drug discovery. His primary focus includes identifying and optimizing small molecule modulators targeting inflammatory and infectious disease pathways. Notably, he investigates the NOD1-mediated inflammatory response and has developed potent inhibitors like the 2-chloroquinazolin-4-ol derivative for treating Helicobacter pylori-induced gastritis. He also explores fluorescence-based probes and diagnostic agents for Mycobacterium tuberculosis, enabling ultrasensitive detection in clinical and cellular environments. Prof. Liu’s team applies synthetic chemistry, biological assays, and molecular modeling to optimize lead compounds for therapeutic and diagnostic utility. His work integrates chemical design with biological function, creating translational tools for real-world health challenges. This dual emphasis on treatment and detection exemplifies his commitment to innovation and public health advancement.

Publication Top Notes

Insights into IrtAB: Iron Transport Facilitates Ultrasensitive Detection of Mycobacteria in Both Cellular and Clinical Environments

Selectively Antagonizing the NOD1-Mediated Inflammatory Signaling Pathway Mitigates the Gastric Inflammation Induced by Helicobacter pylori Infection

Deuterium Editing of Small Molecules: A Case Study on Antitumor Activity of 1,4-Benzodiazepine-2,5-dione Derivatives

From Bench to Clinic: A Nitroreductase Rv3368c-Responsive Cyanine-Based Probe for the Specific Detection of Live Mycobacterium tuberculosis

Optimization of nitrofuranyl calanolides for the fluorescent detection of Mycobacterium tuberculosis

Identification of 1,4-Benzodiazepine-2,5-dione Derivatives as Potential Protein Synthesis Inhibitors with Highly Potent Anticancer Activity

Extracellular vesicles from colorectal cancer cells promote metastasis via the NOD1 signalling pathway 

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China

Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. 📚🧬 She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. 💊 She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. 🌟 Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. 🧠💉 A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. 📈🧫 Dr. Hu’s commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. 🌐🥇

Publication Profile

Orcid

Education

Dr. Yongfang Hu’s academic journey began with a Bachelor’s Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). 🎓💊 She further pursued a Master’s Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. 🔬📘 To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). 🧬📖 Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. 🧠🧪 Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. 🏅📚

Experience

From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. 🏥📘 She later joined Peking University Third Hospital (2005–2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. 🧪📈 Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. 🧬🏥 Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. 💡🎓

Awards and Honors

Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. 🏆 In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. 🎖️ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. 📚👩‍⚕️ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. 🧬🌟 These honors signify her continuous impact on both patient care and the broader medical research landscape. 🧠🏅

Research Focus

Dr. Hu’s research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. 🧬🫀 She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. 🧠💊 She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. 🧫🛡️ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. 👵❤️ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. 📊🔍 Her interdisciplinary approach bridges pharmacology, genomics, and patient care. 🌐🔗

Publication Top Notes

Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study 🧫🧬

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Posted on by Research Hypothesis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Mr Bruno Songel Sanchis, Hospital clínico San Carlos, Spain

Mr. Bruno Songel Sanchis 🎻👓 is a versatile professional with dual expertise in music and vision sciences. Holding a Master’s in Optometry and Vision Sciences from the Complutense University of Madrid 🎓, and a degree in Optics and Optometry from the University of Valencia, he seamlessly combines clinical acumen with research innovation. His extensive clinical experience spans Hospital Clínico San Carlos and Fundación Salud Visual, focusing on cutting-edge myopia control, glaucoma diagnostics, and AI integration in ophthalmology 🤖🧠. Beyond clinics, Bruno’s passion for community service is evident through his impactful volunteer roles and outreach projects 🫶. A talented cellist 🎶 and a committed scientist, he bridges the gap between art and science with grace and dedication. His systematic review on ocular manifestations in IBD showcases his research depth 📄📊. A creative thinker and empathetic clinician, Bruno is a promising contender for the Best Review Paper Award 🥇🧬.

Publication Profile

Orcid

Education

Bruno Songel Sanchis has a rich and interdisciplinary educational background 🎓✨. He earned his Professional Degree in Music (Violoncello) from the Professional Music Conservatory of Valencia 🎻, showcasing his artistic talents. He later pursued a Scientific Baccalaureate at San José de Calasanz High School 🧪📘. Bruno’s scientific journey led him to the University of Valencia, where he obtained his Degree in Optics and Optometry 👁️📐. Committed to advancing vision care, he continued with a Master’s Degree in Optometry and Vision Sciences at the prestigious Complutense University of Madrid 👓🔬. He’s currently engaged in Project Efficiency Boost (2025–present), enhancing clinical productivity through AI and innovation 🚀🤖. His academic versatility reflects both analytical rigor and creativity, a rare blend that empowers his impactful work in clinical practice and scientific research 🧠📚.

Experience

Bruno has extensive hands-on experience in both clinical and research settings 🏥🔬. He served as a Clinical Optometrist at Hospital Clínico San Carlos (Madrid), rotating across subspecialties like myopia, retina, glaucoma, and cataracts 👁️💉. He contributed to pivotal research on myopia control with Atropine and later as a Clinical Research Technician at IdISSC, focused on the ‘LYDIA project’ developing AI diagnostic tools 🤖📊. His role as a Product Specialist marked a major milestone—implementing Europe’s first AI-powered ophthalmic imaging system at La Paz Hospital 🏥✨. Earlier, he worked at Óptica Universitaria and Alain Afflelou, gaining practical skills in optometry, sales, and customer care 🛠️🛍️. Bruno also holds a current role at Fundación Salud Visual (Funsavi), continuing his clinical contributions while mentoring others. These experiences shape him into a well-rounded professional with deep clinical knowledge, technical skills, and patient-centered care focus 👓🫶.

Awards and Honors

Bruno Songel Sanchis has garnered multiple honors for both creativity and scientific excellence 🏆📚. He won 1st prize in the UV Creative Outreach Project (2021) for innovative public science engagement 🎨💡. At the UVemprén Startup – Crea Awards, he secured 3rd position for his entrepreneurial vision in healthcare 🔬🚀. His musical talents earned him an Honorable Mention Diploma at an International Music Seminar, reflecting his multifaceted abilities 🎶🏅. He was also a Finalist in the MOTIVEM UV Awards, acknowledging his academic initiative and leadership 📘👏. As a Rapporteur at the SIYO 2022 Congress for Young Optometrists, he showcased his ability to bridge science and communication 🗣️📊. His certifications from the London School of Hygiene and Tropical Medicine in public health ophthalmology further validate his global competence in preventing blindness and tackling ocular diseases on an international level 🌍👁️.

Research Focus

Bruno Songel Sanchis’s research focuses on clinical optometry, ocular disease prevention, and artificial intelligence applications in ophthalmology 🧠👁️🤖. His major interests include myopia control, particularly using Atropine-based treatments, and early detection of age-related macular degeneration and glaucoma through AI-powered diagnostic systems 🧬📈. In collaboration with top-tier hospitals and research institutions, Bruno played a pivotal role in developing multi-diagnostic tools and conducting clinical trials on visual pathologies. His review on ocular extraintestinal manifestations in inflammatory bowel disease (IBD) offers critical insights into interdisciplinary patient care 📄🩺. A blend of practical clinical work and technical innovation defines his approach, with the goal of improving accessibility and effectiveness of vision care globally 🌐✨. His ongoing contributions to AI integration, coupled with community eye health initiatives, make him a forward-thinking optometrist and researcher committed to impactful, data-driven healthcare advancements 🩻📊.

Publication Top Notes

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review (2024)

 

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways

 

 

 

sang ho choi | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

sang ho choi | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr sang ho choi, Kwangwoon University, South Korea

Assist. Prof. Dr. Sang Ho Choi is an expert in biomedical engineering and artificial intelligence, currently serving as an Assistant Professor at Kwangwoon University, Seoul, Korea 🇰🇷. He leads the Healthcare & AI Lab 🧠🤖. Previously, he worked as a Staff Engineer at Samsung Research 📱. Dr. Choi earned his Ph.D. in Biomedical Engineering from Seoul National University 🎓, focusing on sleep monitoring using deep neural networks 😴🔍. His research interests include biomedical signal processing, AI for healthcare, and IoT systems 🌐. He has published extensively on sleep engineering, neural networks, and health monitoring technologies 📊📚.

Publication Profile

Orcid

Education

Assist. Prof. Dr. Sang Ho Choi is a skilled academic with a Ph.D. in Biomedical Engineering from Seoul National University (2014–2020), where he specialized in unconstrained sleep monitoring and modulation using deep neural networks and closed-loop stimulation. He conducted his research under the guidance of Prof. Kwang Suk Park. Prior to this, he earned a B.S. in Bio-mechatronic Engineering, with a double major in Electronic and Electrical Engineering, from Sungkyunkwan University (2009–2014). He was mentored by Prof. Chang Hyun Choi and Prof. Jitae Shin. His work integrates bioengineering and innovative neural network technologies. 🧠💻🎓

Experience

The research initiatives include groundbreaking work in neuro-chip design and neuro-computing platforms, simulating the human nervous system, funded by the Ministry of Science and ICT (MSIT) Korea (Jul 2022 – Dec 2029) as Co-PI. Another project focuses on intelligent biomedical wireless power transfer, under the National Research Foundation of Korea (NRF) (Mar 2022 – Feb 2024), also as Co-PI. Additionally, the development of AI-based vital signal and sleep monitoring technology using UWB radar is being led as PI (Jul 2021 – Feb 2023) by the NRF. These innovative efforts aim to revolutionize healthcare technology. 🧠💡📡🤖

Research Interest

Assist. Prof. Dr. Sang Ho Choi specializes in biomedical signal processing and analysis, with a strong focus on Artificial Intelligence (AI) applications for biomedical engineering and deep learning. His research spans areas like sleep engineering, healthcare systems, and the integration of Internet of Things (IoT) systems to enhance healthcare outcomes. By leveraging advanced AI techniques, Dr. Choi explores innovative solutions for improving diagnostics, treatment processes, and patient care efficiency. His work aims to merge technology with healthcare, contributing significantly to the future of smart, data-driven medical systems. 🧠💡🩺🤖💻

Ongoing Projects

Assist. Prof. Dr. Sang Ho Choi is a Co-PI on significant national projects funded by Korea’s MSIT and NRF, leading innovative research in the fields of neuro-chip design and AI-driven health monitoring technologies. His work is shaping the future of healthcare by integrating advanced neurotechnology with artificial intelligence. With a passion for cutting-edge scientific advancements, Dr. Choi’s contributions are paving the way for transformative breakthroughs in medical devices and digital health. His dedication to improving healthcare through technological innovation continues to inspire and drive progress in the industry. 🧠💡🤖💊🔬

Research Focus

Assist. Prof. Dr. Sang Ho Choi’s research primarily focuses on biomedical signal processing and health monitoring using advanced sensor technologies. His work includes exploring wearable devices for sleep monitoring, studying the functional connectivity of the amygdala in chronic insomnia patients, and utilizing spiking neural networks for analyzing biomedical signals. He also investigates real-time detection systems, like apnea-hypopnea event detection using radar sensors, and continues to push the boundaries of sensor-based health technologies. His contributions extend to neuroengineering and biomedical engineering, aiming to enhance the accuracy and efficiency of health monitoring systems. 🧠📡💡💤👩‍⚕️

Publication Top Notes

Biomedical Signal Processing and Health Monitoring Based on Sensors

Spiking neural networks for biomedical signal analysis

Amygdala resting-state functional connectivity alterations in patients with chronic insomnia disorder: correlation with electroencephalography beta power during sleep

Technologies for sleep monitoring at home: wearables and nearables

Hybrid CNN-LSTM Network for Real-Time Apnea-Hypopnea Event Detection Based on IR-UWB Radar

Long Short-Term Memory Networks for Unconstrained Sleep Stage Classification Using Polyvinylidene Fluoride Film Sensor

Sleep-Dependent Directional Coupling of Cardiorespiratory System in Patients With Obstructive Sleep Apnea

semih güler | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

semih güler | Medicine and Health Sciences | Best Researcher Award

Mr semih güler, Sivas Numune Hospital, Turkey

Semih Güler 🎓👂 | Born in Sivas (1996), Semih Güler is a dedicated Master Audiologist passionate about advancing the science of audiology and its humanitarian impact. With top honors in his academic journey, including his Master’s from Cappadocia University, he has over five years of experience in diagnosing and treating hearing and balance disorders at Sivas Numune Hospital. Semih has contributed to academia as a lecturer at Cumhuriyet University and published impactful research on anesthesia’s effects on newborn hearing screening. A licensed football player and Turkish Art Music artist, he thrives on discipline, innovation, and mentoring future audiologists. ⚕️🎼⚽

Publication Profile

Orcid

Education and Qualifications

Semih Güler is an accomplished audiologist with a strong academic background. 🌟 He graduated as the top student 🎓 from Serik Anatolian Health Vocational High School Anesthesia and Reanimation Department (2010–2014) with a 92.12/100 score. 📚 He earned an Associate Degree in Audiometry from Ege University (2015–2016) with a stellar 3.86/4 GPA, ranking first. 🏅 Continuing his excellence, he completed a Bachelor’s in Audiology at Üsküdar University (2016–2018) with High Honors (3.62/4). 🎖️ Semih further earned a Master’s in Audiology from Kapadokya University (2019–2021), achieving a perfect 4.0/4 GPA and ranking first in his department and school. 🥇🎓

Experience

Semih Güler is a dedicated audiology professional with a rich career spanning various roles. He began as an Anesthesia Technician at Antalya Yaşam Hospital (2014), leaving to pursue his education 🎓. As an Intern Audiometrist, he trained at Ege University (2014-2016) and later served as an Intern Audiologist at Üsküdar University (2016-2018). Semih currently specializes in Hearing and Balance Disorders at Sivas Numune Hospital, where he has excelled for over five years 👂💡. He also contributed to education as a Lecturer at Cumhuriyet University (2022-2023) and supported individuals with hearing impairments at Yaşam Special Education Center (2018-2020) 📚🤝.

Professional Growth

Semih Güler’s research focus centers on advanced audiology and vestibular studies. With a strong commitment to self-improvement, he has completed numerous advanced training programs and certifications in these fields. His research explores topics such as hearing disorders, balance issues, and the impact of vestibular dysfunction on quality of life. He aims to contribute to the development of innovative diagnostic and therapeutic techniques to improve patient care and outcomes in audiology and vestibular health. 📡🧠🔍

Courses

Semih Güler has a rich background in audiology, vestibular systems, and emergency life support. 🌍🚑 His journey includes an internship in Bucharest, Romania (2013), with Romanian language training. He has completed numerous specialized trainings such as Newborn Hearing Screening 👶👂, Electrophysiology 🎛️, and Vestibular Evaluation 🎯. Semih has participated in national congresses and seminars, enhancing his expertise in audiology innovations and occupational health and safety 🩺. Notable certifications include Clinical v-HIT and f-HIT applications, wideband tympanometry, and vestibular migraine assessment 🎓. Dedicated to professional growth, Semih contributes to hearing and balance science while aligning with European and Turkish standards. ✨

Achievements

Mr. Semih Güler has excelled in his academic journey, achieving remarkable milestones 🎓🌟. He graduated first in his class from Serik Anatolian Health Vocational High School’s Anesthesia and Reanimation Department 🏅 and Ege University’s Atatürk Health Services Vocational School Audiometry Program 🥇. As a high-honor student at Üsküdar University’s Faculty of Health Sciences in Audiology 📘, he continued to shine academically. His dedication culminated in earning a Master’s Degree in Audiology with a thesis from Cappadocia University’s Graduate Education and Research Institute, where he also ranked first in his department 🥇📜. His achievements reflect his dedication and excellence! 🌟👏

Research Focus

Semih Güler’s research focuses on the effects of delivery type and anesthesia method on Auditory Brainstem Response (ABR) results in newborns. His study, published in the International Journal of Pediatric Otorhinolaryngology, investigates how different delivery methods and anesthesia impact ABR outcomes, which are crucial for newborn hearing screening. The aim is to understand how these factors influence auditory health at an early stage, contributing valuable insights for clinical practices and guidelines in neonatal care. 🌟🎧🔬

Publication Top notes

Effect of type of delivery and anesthesia method to ABR results on Newborn Hearing Screening